By Mrinalika Roy Oct 28 (Reuters) - Women in the US struggling to find hormone replacement treatments to manage menopause ...
Demand for menopause drugs is now outpacing supply across multiple estrogen products in the US. After months of tight ...
Estrogen patches are the most commonly reported shortage in the U.S., but the FDA says it’s working to boost supply.
Shortages of estrogen patches have spread to injectable and vaginal hormone treatments as demand for menopause therapy rises, ...
When 56-year-old Lila Davachi began the menopause transition several years ago, she was caught off guard by the severe brain fog. Davachi, a neuroscientist and professor, knows the brain well. But she ...
The FDA is facing mounting pressure to declare an estrogen patch shortage as some medical providers say production isn't keeping up with demand.
The U.S. Food and Drug Administration (FDA) approved the first generic version of Climara Pro on Monday. It’s a skin patch ...
FDA approved the first generic Climara Pro, a weekly estrogen-progestin patch, as women report trouble filling patches. What ...
Add Yahoo as a preferred source to see more of our stories on Google. Alexis Dunne always plans how to best treat her patients' perimenopause and menopause symptoms. The Chicago-area physician wants ...
AAM highlights essential role generics manufacturers play in supplying estrogen patches; notes the complexity of its production and reasons for not declaring a nationwide shortage ...
Tammy Duckworth, Kirsten Gillibrand and Adam Schiff urge the FDA to address the estradiol patch shortage disrupting menopause ...
If you’ve been struggling to fill your estrogen patch prescription, you’re not alone. Here’s what to know and what to do next. Getty Images Estrogen patches are making national headlines, and if ...